Inhalerx Ltd (irx) Logo

Inhalerx Ltd (IRX)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

IRX ASX Chart

Snapshot

InhaleRx Limited (IRX) is an Australian healthcare company which is developing unique medicinal drug-device products to address unmet medical needs in pain management and mental health sectors.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -41.29%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 2,055 of 2,382
Sector Rank 200 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies OSP / SIL / CGB
EPS -$0.013
DPS $0.00
Book Value Per Share $0.01

Broker Consensus

IRX is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Melbourne VIC 3000
Website www.InhaleRx.com.au
Registry Automic Group
Auditor HLB Mann Judd
Date Listed 11 Jan 2017

Upcoming Calendar (Forecasted)

Date Event
26/04/2024 Report (Quarterly)
20/08/2024 Report (Interim)
12/02/2025 Report (Prelim)
27/03/2025 Report (Annual)

Former Company Names

  • Lifespot Health Ltd (LSH), 06/10/2021

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

IRX directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
11/07/23 Sean Williams Issued 2,000,000 $0.047 $94,000 Issue of options
28/11/22 Sean Williams Issued 2,000,000 $0.054 $108,000 Issue of options
01/12/21 Sean Williams Buy +200,000 $0.095 $18,917 On-market trade
11/10/21 Darryl Davies Buy +305,248 $0.105 $32,051 On-market trade

Director Interests

The current holdings of IRX directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
James Barrie 01/03/2024 0 N/A N/A N/A
Sean Williams 11/07/2023 0 200,000 4,000,000 N/A
Andrew Saich 20/07/2021 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Mar 7, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Cannvalate Pty Ltd 36,024,924 18.98%
10 Bolivianos Pty Ltd 22,267,452 11.73%
Pyxis Holdings Pty Ltd 10,800,000 5.69%
Bnp Paribas Noms Pty Ltd 10,033,902 5.29%
Superhero Securities Limited 9,299,640 4.90%
Mcann Investments Pty Ltd 8,000,000 4.22%
Parim Singh Harman Singh 6,249,999 3.29%
BNP Paribas Nominees Pty Ltd (i) 5,074,905 2.67%
Bliss On Banksia Hairdressing Pty Ltd 4,200,340 2.21%
Bay Private Equity Inc 3,333,333 1.76%
HSBC Custody Nominees (Australia) Limited 3,311,339 1.74%
Dr David James Walland 3,172,961 1.67%
Mr Niv Dagan 2,782,013 1.47%
Mr Sean Christopher Reeves 2,567,818 1.35%
BNP Paribas Nominees Pty Ltd (ii) 2,528,281 1.33%
Apertus Capital Pty Ltd 2,000,000 1.05%
Mr Piper Belesprit Madison 1,800,038 0.95%
Mr Daniel Richard Evans 1,770,990 0.93%
Mr Michael James Reid 1,653,478 0.87%
Netwealth Investments Limited 1,604,351 0.85%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
BNP Parabas Noms Pty Ltd 07/03/2023 10,033,902 5.29
Cannvalate Pty Ltd 07/03/2023 36,024,924 18.98
10 Bolivianos Pty Ltd 07/03/2023 22,267,452 11.73
Pyxis Holdings Pty Ltd 07/03/2023 10,800,000 5.69

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.040 30 June
2022 $0.073 30 June
IRX Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.